Report #2857011

Received Sep 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 74 yrs
State: NY
Recovered: Unknown
Vaccinated: Aug 25, 2025
Onset: Aug 25, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	GJ952	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Her second Shingrix dose was mistakenly given early on 25 Aug 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number GJ952, expiry date 25-APR-2027) for prophylaxis. Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX). On 25-AUG-2025, the patient received the 2nd dose of Shingrix. On 25-AUG-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Her second Shingrix dose was mistakenly given early on 25 Aug 2025). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK Receipt Date: 26-AUG-2025 The reporter was the pharmacist. A female patient received her first Shingrix dose. Her second Shingrix dose was mistakenly given early which led to drug dose administration interval too short. Nothing else was reported.